106 related articles for article (PubMed ID: 16515926)
1. Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma.
Lardinois D; Jung FJ; Opitz I; Rentsch K; Latkoczy C; Vuong V; Varga Z; Rousson V; Günther D; Bodis S; Stahel R; Weder W
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):697-703. PubMed ID: 16515926
[TBL] [Abstract][Full Text] [Related]
2. Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
Opitz I; Lardinois D; Arni S; Hillinger S; Vogt P; Odermatt B; Rousson V; Weder W
Eur J Cardiothorac Surg; 2007 May; 31(5):773-8. PubMed ID: 17350855
[TBL] [Abstract][Full Text] [Related]
3. Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting.
Ampollini L; Soltermann A; Felley-Bosco E; Lardinois D; Arni S; Speck RF; Weder W; Opitz I
Eur J Cardiothorac Surg; 2009 Mar; 35(3):457-62. PubMed ID: 19162494
[TBL] [Abstract][Full Text] [Related]
4. Optimized intrapleural cisplatin chemotherapy with a fibrin carrier after extrapleural pneumonectomy: a preclinical study.
Opitz I; Erne BV; Demirbas S; Jetter A; Seifert B; Stahel R; Weder W
J Thorac Cardiovasc Surg; 2011 Jan; 141(1):65-71. PubMed ID: 21168013
[TBL] [Abstract][Full Text] [Related]
5. Innovative therapies: intraoperative intracavitary chemotherapy.
Chang MY; Sugarbaker DJ
Thorac Surg Clin; 2004 Nov; 14(4):549-56. PubMed ID: 15559062
[TBL] [Abstract][Full Text] [Related]
6. Intrapleural polymeric films containing cisplatin for malignant pleural mesothelioma in a rat tumour model: a preliminary study.
Ampollini L; Sonvico F; Barocelli E; Cavazzoni A; Bilancia R; Mucchino C; Cantoni AM; Carbognani P
Eur J Cardiothorac Surg; 2010 Mar; 37(3):557-65. PubMed ID: 19766508
[TBL] [Abstract][Full Text] [Related]
7. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
Tilleman TR; Richards WG; Zellos L; Johnson BE; Jaklitsch MT; Mueller J; Yeap BY; Mujoomdar AA; Ducko CT; Bueno R; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):405-11. PubMed ID: 19619785
[TBL] [Abstract][Full Text] [Related]
8. Hypotonic intrapleural cisplatin chemotherapy as treatment for pleural carcinomatosis in an experimental model.
Katano K; Tsujitani S; Saito H; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 1997; 17(6D):4547-52. PubMed ID: 9494566
[TBL] [Abstract][Full Text] [Related]
9. High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses.
Lerza R; Esposito M; Vannozzi M; Bottino GB; Bogliolo G; Pannacciulli I
Cancer; 1994 Jan; 73(1):79-84. PubMed ID: 8275441
[TBL] [Abstract][Full Text] [Related]
10. Regional pharmacokinetic selectivity of intrapleural cisplatin.
Bogliolo GV; Lerza R; Bottino GB; Mencoboni MP; Pannacciulli IM; Vannozzi M; Fulco RA; Merlo F; Esposito M
Eur J Cancer; 1991; 27(7):839-42. PubMed ID: 1834113
[TBL] [Abstract][Full Text] [Related]
11. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
[TBL] [Abstract][Full Text] [Related]
12. A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma.
Zellos L; Richards WG; Capalbo L; Jaklitsch MT; Chirieac LR; Johnson BE; Bueno R; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2009 Feb; 137(2):453-8. PubMed ID: 19185169
[TBL] [Abstract][Full Text] [Related]
13. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
[TBL] [Abstract][Full Text] [Related]
14. Systemic and tissue chamber fluid platinum concentrations released from cis-diamminedichloroplatinum II-impregnated polymethylmethacrylate in healthy dogs.
Buss MS; Henry CJ; Tyler JW; Tobias KS; Daoud S; Hoopes J; Moore MP
Am J Vet Res; 1999 Mar; 60(3):280-3. PubMed ID: 10188807
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of hypotonic cisplatin chemotherapy administered into the peritoneal and the pleural cavities in experimental model.
Katano K; Tsujitani S; Oka S; Saito H; Gomyo Y; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 2000; 20(3A):1603-7. PubMed ID: 10928078
[TBL] [Abstract][Full Text] [Related]
17. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA
Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tissue distribution of iv injection of polyphase liposome-encapsulated cisplatin (KM-1) in rats.
Wang S; Mi JB; Li YZ; Chang WB; Ci YX; Zhao MZ; Zhao YK; Zhu LY; Xu G
Acta Pharmacol Sin; 2003 Jun; 24(6):589-92. PubMed ID: 12791187
[TBL] [Abstract][Full Text] [Related]
19. Isolated lung perfusion with cisplatin in a rat lung solitary tumor nodule model.
Li TS; Sugi K; Ueda K; Nawata K; Nawata S; Esato K
Anticancer Res; 1998; 18(6A):4171-6. PubMed ID: 9891463
[TBL] [Abstract][Full Text] [Related]
20. Phase I and pharmacokinetic study of pemetrexed plus cisplatin in chemonaive patients with locally advanced or metastatic malignant pleural mesothelioma or non-small cell lung cancer.
Dickgreber NJ; Fink TH; Latz JE; Hossain AM; Musib LC; Thomas M
Clin Cancer Res; 2009 Jan; 15(1):382-9. PubMed ID: 19118069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
